DrFuhrman.com discontinues supplement cancer claims following National Advertising Division challenge

NEW YORK — DrFuhrman.com on Monday informed the National Advertising Division that the company has discontinued certain advertising claims — including “anti-cancer” and cancer treatment claims — made for the company’s Immunotect dietary supplement.

The claims at issue were challenged by the Council for Responsible Nutrition.

NAD is an investigative unit of the advertising industry’s system of self-regulation. It is administered by the Council of Better Business Bureaus.

As part of its routine monitoring program, and in conjunction with NAD’s initiative with CRN to expand the review of advertising claims made for supplements, NAD requested that DrFuhrman provide substantiation for more than a dozen claims.